01 VALPROIC ACID (3)
01 BIONPHARMA (3)
01 CAPSULE, DELAYED RELEASE;ORAL (3)
01 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
02 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
03 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 USA (3)
19
Bionpharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is VALPROIC ACID, with a corresponding application number 22152 and regulatory information .
proudly manufactured in the
approval since 2008-07-29
Bionpharma's STAVZOR CAPSULE, DELAYED RELEASE;ORAL, medication with 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of VALPROIC ACID.
18
Bionpharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is VALPROIC ACID, with a corresponding application number 22152 and regulatory information .
proudly manufactured in the
approval since 2008-07-29
Bionpharma's STAVZOR CAPSULE, DELAYED RELEASE;ORAL, medication with 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of VALPROIC ACID.
17
Bionpharma, based in U.S.A, is a pharmaceutical company.
One of their notable products is VALPROIC ACID, with a corresponding application number 22152 and regulatory information .
proudly manufactured in the
approval since 2008-07-29
Bionpharma's STAVZOR CAPSULE, DELAYED RELEASE;ORAL, medication with 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of VALPROIC ACID.